Press Releases

Media Mentions

  • May 06, 2020

    Partnership to Identify IPF Biomarkers Aimed at Enabling Optimal Patient Treatment

    The Pulmonary Fibrosis Foundation (PFF) has co-founded an industry-wide effort to identify new blood biomarkers specific to IPF with the goal of predicting which patients would benefit most from certain medications.

    Read the Article
    Source: Responsum for PF
  • Mar 09, 2020

    Pulmonary Fibrosis Foundation Launches Industry Consortium to Identify Biomarkers in Pulmonary Fibrosis

    The Pulmonary Fibrosis Foundation (PFF) today announced a new collaboration that could speed up the development of targeted treatments for individuals with idiopathic pulmonary fibrosis (IPF), a devastating and progressive lung disease.

    Read the Article
    Source: Clinical Labs Products
  • Mar 04, 2020

    Pulmonary Fibrosis Foundation, Celgene Form Biomarker Consortium

    The Pulmonary Fibrosis Foundation (PFF) has partnered with Bristol-Myers Squibb subsidiary Celgene to launch a research consortium to identify biomarkers of pulmonary fibrosis that can guide therapy.

    Read the Article
    Source: GenomeWeb